By James Paton Bloomberg
- All
- News
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Omicron Subvariant BA.2 Is Gaining Ground. Should We Worry?
Two years into the pandemic, a mutated version of the omicron variant, known as BA.2, has become the latest challenge to taming COVID-19.
-
When Will Covid Pandemic Really End? What Covax Says
On Jan. 23, 2020, the day the novel coronavirus forced the Chinese city of Wuhan into lockdown, two American doctors named Seth Berkley and Richard Hatchett met at the bar of the Hard Rock Hotel in Davos, Switzerland, to talk about vaccines.
-
Rise Of Variants Sparks Push For All-In-One Coronavirus Vaccines
Just weeks into the rollout of vaccines to combat Covid-19, researchers are shifting their focus to a new class of potential shots to take on the threat posed by fast-spreading mutations.
-
Oxford Vaccine Effective But Questions On Those Above 55: Report
On the day Britain began immunizing its population with a Covid-19 shot developed by Germany's BioNTech SE and the U.S.'s Pfizer Inc., a peer-reviewed study of the U.K.'s homegrown vaccine left some key questions unanswered.
-
UK Clears Vaccine Before US, Europe: "By Spring, Will Be Through This"
The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE's shot ahead of decisions in the U.S. and European Union.
-
UK Considers Infecting People With Covid To Aid Vaccine Efforts
Alex Greer says he'd rather put himself directly in the path of the coronavirus than get blindsided by the disease after an evening at the pub or with friends. It's a scenario that could soon become a reality.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Omicron Subvariant BA.2 Is Gaining Ground. Should We Worry?
Two years into the pandemic, a mutated version of the omicron variant, known as BA.2, has become the latest challenge to taming COVID-19.
-
When Will Covid Pandemic Really End? What Covax Says
On Jan. 23, 2020, the day the novel coronavirus forced the Chinese city of Wuhan into lockdown, two American doctors named Seth Berkley and Richard Hatchett met at the bar of the Hard Rock Hotel in Davos, Switzerland, to talk about vaccines.
-
Rise Of Variants Sparks Push For All-In-One Coronavirus Vaccines
Just weeks into the rollout of vaccines to combat Covid-19, researchers are shifting their focus to a new class of potential shots to take on the threat posed by fast-spreading mutations.
-
Oxford Vaccine Effective But Questions On Those Above 55: Report
On the day Britain began immunizing its population with a Covid-19 shot developed by Germany's BioNTech SE and the U.S.'s Pfizer Inc., a peer-reviewed study of the U.K.'s homegrown vaccine left some key questions unanswered.
-
UK Clears Vaccine Before US, Europe: "By Spring, Will Be Through This"
The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE's shot ahead of decisions in the U.S. and European Union.
-
UK Considers Infecting People With Covid To Aid Vaccine Efforts
Alex Greer says he'd rather put himself directly in the path of the coronavirus than get blindsided by the disease after an evening at the pub or with friends. It's a scenario that could soon become a reality.
